-
White Blood Cell and Urine Collection in LRRK2 and GBA Mutation Carriers
… Study Design: We aim to collect urine samples and PBMCs from participants with and without LRRK2 or GBA mutations … If we can successfully collect urine and blood samples from mutation carriers and non-carriers, the next step is to …
-
Parkinson's Researchers Raise Their Voices on Capitol Hill
March 4, 2019
… "It's so important for members of Congress to hear directly from the scientific community about the benefits of federal … at Michigan State University who received a grant from the DoD. "By showcasing what federal funding can do, I …
-
Cerium Oxide Nanoparticles in Treatment of Parkinson's Disease
… in signaling molecules, and ascertain whether protection from neurodegeneration is afforded by cerium oxide … nanoparticle treatment will protect dopaminergic neurons from degeneration and death associated with chemical …
-
Development of modulators of alpha-synuclein conformation for PD therapeutics
… This grant builds upon the research from a prior grant: Development of SHG to Discover Drugs to … commercially available structural analogs of the hits from various sources, including the NINDS library of …
-
Feasibility of Intranasal Delivery of GDNF for Parkinson's Disease
… and reach the brain to protect dopamine neurons from the neurotoxin 6-hydroxydopamine (6-OHDA), a standard … amounts of GDNF to brain to protect dopamine neurons from the neurotoxic effects of 6-OHDA in rats, and to …
-
The oscillation of basal ganglia
… content of electrical activities recorded directly from the basal ganglia in patients undergoing deep brain … Meeting. Drs. Chen and Moro obtained follow-on funding from the Canadian Institutes of Health Research (a Canadian …